Camerino, Italy

Giancarlo Gioia Lobbia

This inventor holds 1 USPTO granted patent. Top assignees: Università Degli Studi Di Camerino, Universitá Degli Studi Di Padova. Active years: 2015.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Giancarlo Gioia Lobbia. Retrieved from https://idiyas.com/inventor/giancarlo-gioia-lobbia

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


Average Co-Inventor Count = 8.0

ph-index = 1

Forward Citations = 2(Granted Patents)


Company Filing History:


Years Active: 2015

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Giancarlo Gioia Lobbia: Innovator in Antineoplastic Agents

Introduction

Giancarlo Gioia Lobbia is a notable inventor based in Camerino, Italy. He has made significant contributions to the field of medicine, particularly in the development of compounds for the treatment of human solid tumors. His innovative work has the potential to impact cancer treatment positively.

Latest Patents

Giancarlo holds a patent for the compound [Cu(thp)4][X]-n, which is designed for the treatment of a broad range of human solid tumors, including refractory tumors. This patent involves Cu(I) complexes of the type [Cu(thp)4][X], where thp is a tris(hydroxymethyl)phosphine, and X represents a counteranion. The invention is aimed at providing antineoplastic agents against solid tumors in humans.

Career Highlights

Throughout his career, Giancarlo has worked with prestigious institutions such as the University of Padua and the University of Camerino. His research has focused on developing innovative solutions to combat cancer, showcasing his dedication to advancing medical science.

Collaborations

Giancarlo has collaborated with notable colleagues, including Cristina Marzano and Marina Porchia. These partnerships have contributed to the success of his research and the development of his patented compounds.

Conclusion

Giancarlo Gioia Lobbia's work in the field of antineoplastic agents highlights his commitment to improving cancer treatment. His innovative patents and collaborations with esteemed institutions and colleagues underscore his significant contributions to medical research.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…